Shu‐Yang Hu

机构：Fudan University, Zhongshan Hospital · ORCID：0000-0003-0961-0318

发表论文 6 篇 · 总被引 61 次 · h-index 4

代表论文

• The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion (2022 · Hepatology International · 被引 35)
• The LINC00261/MiR105-5p/SELL axis is involved in dysfunction of B cell and is associated with overall survival in hepatocellular carcinoma (2022 · PeerJ · 被引 12)
• Lysine‐specific demethylase 1 deletion reshapes tumour microenvironment to overcome acquired resistance to anti‐programmed death 1 therapy in liver cancer (2025 · Clinical and Translational Medicine · 被引 10)
• Application of a single-cell-RNA-based biological-inspired graph neural network in diagnosis of primary liver tumors (2024 · Journal of Translational Medicine · 被引 4)
• FGFR2 fusion-driven CXCL3 downregulation attenuates neutrophil recruitment in intrahepatic cholangiocarcinoma (2026 · Cancer Letters)
• Application of a Single-Cell-RNA-Based Biological-Plausible Graph Neural Network in Diagnosis of Primary Liver Tumours (2023 · SSRN Electronic Journal)